Suppr超能文献

卷柏全草中的改性枞型二萜。

Modified Abietane Diterpenoids from Whole Plants of Selaginella moellendorffii.

机构信息

Key Laboratory of Economic Plants and Biotechnology and Yunnan Key Laboratory for Wild Plant Resources, State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences , Kunming 650201, People's Republic of China.

Southeast Asia Biodiversity Research Institute, Chinese Academy of Sciences , Yezin, Nay Pyi Taw 05282, Myanmar.

出版信息

J Nat Prod. 2018 Feb 23;81(2):418-422. doi: 10.1021/acs.jnatprod.7b00909. Epub 2018 Feb 7.

Abstract

A new modified abietane diterpenoid, (3S,4S,5R,10S)-18(4→3)-abeo-3,4,12,18-tetrahydroxy-8,11,13-abietatrien-7-one (1), and two novel dimers, selaginedorffones A (2) and B (3), featuring a new cyclohexene moiety that was biogenetically constructed from two modified abietane diterpenoids through a Diels-Alder reaction were obtained from a methanolic extract of Selaginella moellendorffii, a traditional Chinese herb. The structures of 1-3 were identified by a combination of NMR spectroscopic analysis and ECD calculations. In the present study, diterpenoids were identified from S. moellendorffii for the first time, which supports the presence of diterpene synthases in this plant. These three diterpenoids (1-3) were evaluated for their growth-inhibitory activities against several human cancer cell lines. Of these substances, selaginedorffone B (3) showed cytotoxicity against the MCF-7 human-breast-cancer-cell line (IC 9.0 μM).

摘要

从中国传统草药卷柏(Selaginella moellendorffii)的甲醇提取物中获得了一种新的修饰的松香烷二萜类化合物(3S,4S,5R,10S)-18(4→3)-abeo-3,4,12,18-四羟基-8,11,13-松香三烯-7-酮(1)和两个新的二聚体,selaginedorffones A(2)和 B(3),其特征在于一个新的环己烯部分,该部分是通过 Diels-Alder 反应从两种修饰的松香烷二萜生物构建的。通过 NMR 波谱分析和 ECD 计算的组合鉴定了 1-3 的结构。在本研究中,首次从卷柏中鉴定出二萜类化合物,这表明该植物中存在二萜合酶。这三种二萜类化合物(1-3)被评估对几种人类癌细胞系的生长抑制活性。在这些物质中,selaginedorffone B(3)对 MCF-7 人乳腺癌细胞系表现出细胞毒性(IC 9.0 μM)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验